Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Visani

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
Leukemia|May 17, 2003
Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case reportP P Piccaluga, G Visani, A Isidori, et al.
Leukemia & Lymphoma|September 1, 1994
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemiaG Visani, P Tosi, A Cenacchi, et al.
Blut|November 1, 1990
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119)F Verlicchi, S Boschi, G Visani, et al.
European Journal of Haematology. Supplementum|January 1, 1989
In vitro growth of myeloma cellsG Visani, R M Lemoli, P Tosi, et al.
Transplantation|December 1, 1989
Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferationG Visani, R M Lemoli, A Dinota, et al.
Blood|December 15, 1992
tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppressionG Zauli, B R Davis, M C Re, et al.
American Journal of Epidemiology|March 15, 1994
Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study GroupA Mele, M Szklo, G Visani, et al.
Blood|September 25, 2001
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignanciesP Secchiero, A Gonelli, C Celeghini, et al.
Annals of Hematology|June 1, 1993
Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitorsG Visani, M Fogli, P Tosi, et al.
Lancet (London, England)|February 28, 1987
Viability of autologous bone marrowG Bandini, P Ricci, R M Lemoli, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
Leukemia|May 17, 2003
Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case reportP P Piccaluga, G Visani, A Isidori, et al.
Leukemia & Lymphoma|September 1, 1994
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemiaG Visani, P Tosi, A Cenacchi, et al.
Blut|November 1, 1990
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119)F Verlicchi, S Boschi, G Visani, et al.
European Journal of Haematology. Supplementum|January 1, 1989
In vitro growth of myeloma cellsG Visani, R M Lemoli, P Tosi, et al.
Transplantation|December 1, 1989
Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferationG Visani, R M Lemoli, A Dinota, et al.
Blood|December 15, 1992
tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppressionG Zauli, B R Davis, M C Re, et al.
American Journal of Epidemiology|March 15, 1994
Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study GroupA Mele, M Szklo, G Visani, et al.
Blood|September 25, 2001
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignanciesP Secchiero, A Gonelli, C Celeghini, et al.
Annals of Hematology|June 1, 1993
Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitorsG Visani, M Fogli, P Tosi, et al.
Lancet (London, England)|February 28, 1987
Viability of autologous bone marrowG Bandini, P Ricci, R M Lemoli, et al.
Pageof 22